COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals to Present and Participate in Panel Discussion at World Vaccine Congress, Europe 2025
09/10/2025
CHATHAM, N.J., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biotechnology company with marketed products and a pipeline of [...]
Grow Up Conference & Expo Debuts in Vancouver
09/10/2025
B2B cannabis event returns to B.C. for three days of education and business-building Vancouver, B.C., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Grow Up Conference & Expo (“Grow Up”), Canada’s largest B2B cannabis event, [...]
Humber River Health Achieves Excellent Scores, Remarkably Low Rate of Patient Harm, Leading Provincial and National Benchmarks
09/10/2025
TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Humber River Health has reported a significantly lower rate of patient harm compared to both provincial and national averages, underscoring the organization’s commitment to [...]
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
09/10/2025
Event to be held October 14th at 4 p.m. EST BETHESDA, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [...]
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community
09/10/2025
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced it is [...]
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income
09/10/2025
Operational Efficiencies and Focus on Profitability Drove Net Income of $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million Year-Over-Year Canadian Adult-Use [...]
Dr. Mark Hyman joins ADvantage Therapeutics Advisory Board to further advance Klotho-Based Longevity Programs at Klothea Bio
09/10/2025
World-renowned longevity physician to help guide Klothea Bio as it prepares for a Phase 1B clinical trial of its Klotho therapeutic for aging related diseases MIAMI, Oct. 09, 2025 (GLOBE NEWSWIRE) -- ADvantage [...]
Genvor Restores Trading Status and Expands Global Collaborative Research Network
09/10/2025
Woodland, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCID: GNVR), a pioneer in AI-accelerated peptide technology for sustainable agriculture, today announced that it has regained active OTCQB trading status on [...]
Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform
09/10/2025
ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient testing solutions for [...]
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade
09/10/2025
Ingelheim, Germany/Ridgefield, Connecticut, U.S. Idiopathic pulmonary fibrosis (IPF) is a progressive disease, causing a continuous decline in lung function. 1 Approval is based on results from two clinical trials, [...]
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
09/10/2025
Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share Advances Akero’s Mission of Bringing Novel Therapies to Patients with High Unmet Medical Needs SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE [...]
Human Appeal's Pot of Gold Film to Air on EarthX Channel on October 18
09/10/2025
BayView Entertainment to Bring Groundbreaking Documentary to Streaming and Broadcast Audiences MISSION VIEJO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Pot of Gold , a powerful independent documentary set in the [...]
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio
09/10/2025
Acquisition adds potential first- and best-in-class asset, enhancing Novo Nordisk’s portfolio for treatment of MASH, one of the most prevalent obesity related comorbidities Akero Therapeutics’s FGF21 analogue [...]
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
09/10/2025
STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
09/10/2025
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Italfarmaco Appoints Francesco Di Marco as Chief Executive Officer
09/10/2025
MILAN, Italy, October 09, 2025 – Italfarmaco S.p.A. today announced that Dr. Francesco Di Marco has been appointed as Chief Executive Officer (CEO), effective January 1, 2026. Dr. Di Marco brings over 25 years of [...]
Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA™ / SOFTAG™ breast implant
09/10/2025
24-month Phase I follow-up data show positive outcomes are maintained High levels of investigator and patient satisfaction, excellent safety profile Ongoing registrational trial will yield top-line results before the [...]
Ariceum Therapeutics Data at the 2025 European Association of Nuclear Medicine Annual Congress Further Supports the Advancement of 225Ac-SSO110 for Extensive Stage Small Cell Lung Cancer and Merkel Cell Carcinoma
09/10/2025
Oral presentation by Dr Zan highlighted novel Phase 1/2 SANTANA-225 study design of 225Ac-SSO110 in patients with ES-SCLC or MCC 225Ac-SSO110 achieves superior pharmacokinetics with minimal re-distribution of Actinium- [...]
Zelluna Receives Positive MHRA Feedback and Strengthens UK Clinical Strategy for ZI-MA4-1 Paving the Way for First-in-Human Trials in the UK
09/10/2025
On track to file CTA by year end 2025, with plan to dose first patients and deliver initial data in 2026 Planned UK trial to be led by Prof. Fiona Thistlethwaite at The Christie NHS Foundation Trust, a European hub for [...]

Pages